A carregar...
Yescarta: A New Era for Non-Hodgkin Lymphoma Patients
The use of conventional therapeutic approaches in patients with lymphoma demonstrates significant drug resistance leading to poor prognosis with reduced median survival period. T-cell immunotherapy has diverted huge attention of the researchers in recent times to engage in the stated research studie...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7744214/ https://ncbi.nlm.nih.gov/pubmed/33354449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.11504 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|